Gilead Sciences, Inc. technical analysis
Technical analysis of Gilead Sciences, Inc. (stock) with the Montbon Method — Elliott Waves, moving averages and a 0–100 score.
What is Gilead Sciences, Inc.
Gilead Sciences is a biopharmaceutical company that discovers, develops, and commercializes medicines in areas of unmet medical need. The company offers medications for the treatment of HIV-1 infection, chronic hepatitis C virus, chronic hepatitis B virus, and primary biliary cholangitis, as well as CAR T-cell therapies and immunotherapies for cancer patients. Gilead maintains collaboration agreements with various organizations for research and development of new treatments.
Description generated automatically from public sources; it may be inaccurate or out of date.
Gilead Sciences, Inc.: latest session data
Closing values for September 4, 2026, computed on the last 12 months of prices.
Moving averages
21 sessions
143.78 $
+4.55%
50 sessions
136.59 $
+10.05%
200 sessions
133.38 $
+12.70%
Session levels
s2
147.30
Support
s1
149.26
Support
pivot
150.37
Pivot
r1
152.33
Resistance
r2
153.44
Resistance
How to read it
In the September 4, 2026 session Gilead Sciences, Inc. closed lower at 150.32 $, −0.60% versus the previous session.
The price sits above every moving average observed: +4.55% against the 21-session average, +10.05% against the 50 and +12.70% against the 200.
The 14-period RSI reads 65.9, in neutral territory.
MACD stands at 4.281 against a signal line at 4.046: the histogram is positive (+0.234).
ADX reads 39.8, indicating a marked directionality.
Levels computed on the latest session place supports at 149.26 and 147.30 $ and resistances at 152.33 and 153.44 $, around a pivot of 150.37.
The average daily range (ATR) is 3.615 $, or 2.40% of price.
Turnover was 2.3M shares, 45% of the 20-session average.
Over the last twelve months the price ranged between 120.60 and 152.55 $, and today stands −1.46% from the period high.
Measures computed on closing prices. They describe the past; they are not forecasts.
Score, Elliott Waves, moving averages and technical indicators — free, no card
If you're not registered we'll ask you to sign in (free), then open the GILD analysis.
How Montbon’s technical analysis works
Montbon analyses markets with Elliott Waves, multi-timeframe moving averages and a 0–100 score summarising the technical setup. It is an informational screening tool.
Elliott Waves
Wave counting to frame the price structure.
MTF moving averages
Moving averages across timeframes to read the trend.
0–100 score
A technical summary of the setup, updated daily.
FAQ about Gilead Sciences, Inc.
How is Gilead Sciences, Inc. analysed technically?
Technical analysis of Gilead Sciences, Inc. is based on price charts and indicators such as moving averages, RSI and MACD, to observe trend, momentum and volatility across different time horizons.
Which timeframes are used for Gilead Sciences, Inc.?
The daily and weekly charts are typically used for medium-to-long-term trends, while intraday charts (for example 1-hour or 15-minute) are used for short-term movements.
What are Elliott Waves applied to Gilead Sciences, Inc.?
Elliott Wave theory describes price moves as sequences of impulsive and corrective waves; applied to Gilead Sciences, Inc. it helps frame the technical structure of the historical chart and is not a forecast.
Other tickers to analyse
Disclaimer. For informational purposes only; not financial advice or a recommendation. Montbon Analytics is not an authorised financial intermediary.
Are you an issuer and want a correction or removal? Write to info@montbon.com.